ADVFN Logo

Hot Features

Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.

SAGE Sage Therapeutics Inc

18,74
-0,30 (-1,58%)
29 Mar 2024 - Fermé
Retardé de 15 minutes

Période:

Mode Dessin:

Volume 1 004 673
Prix Achat 18,51
Prix Vente 19,25
Actualités -
Maximum Haut 19,34

Bas
16,515

Sur 52 semaines

Haut
59,99

Minimum Bas 18,51
Nom Action Symbole Action Marché Type
Sage Therapeutics Inc SAGE NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
-0,30 -1,58% 18,74 01:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
19,06 18,51 19,34 18,74 19,04
Transactions Totales Volume échangé VWAP Volume Financier Volume en moyenne Sur 52 semaines
10 312 1 004 673 US$ 18,70 US$ 18 782 818 - 16,515 - 59,99
Dernière Transaction Type Quantités échangées Prix transaction Devise
21:04:22 26 US$ 18,74 USD

Flux d'options Sage Therapeutics (SAGE)

Flux global

Haussier

Prime nette

177k

Calls / Puts

100,00%

Ach. / Vent.

100,00%

OTM / ITM

0,00%

Sweeps Ratio

0,00%

Bilan Comptable

Capitalisation Boursière Actions en Circulation Float Chiffre d'affaires Bénéfice/Perte BPA Ratio Cours sur Bénéfices
1,13B 60,11M - 86,46M -541,49M -9,01 -
Short Interest Dividendes Par Action Rendement du Dividende Ex-Div Date Insider B/S Insider % Owned
- - - -

plus d’informations financières »

Actualités Action Sage Therapeutics

Date Heure Source Titre
28/2/202412:30Business WireSage Therapeutics to Present at Upcoming March Investor..
21/2/202422:35Edgar (US Regulatory)Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
15/2/202423:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
15/2/202423:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
14/2/202422:09Edgar (US Regulatory)Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
14/2/202413:49Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee..
14/2/202413:20Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K..
14/2/202412:45Edgar (US Regulatory)Form 8-K - Current report
14/2/202412:30Business WireSage Therapeutics Announces Fourth Quarter and Full Year..
31/1/202423:25Edgar (US Regulatory)Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
31/1/202422:50Edgar (US Regulatory)Form 8-K - Current report
31/1/202412:30Business WireSage Therapeutics to Report Fourth Quarter and Full Year..

Forum Action Sage Therapeutics

Aucune Discussion TrouvéeAjouter une Discussion

Historiques Sage Therapeutics Inc

Période Ouver. Haut Bas VWAP Moyenne Vol. Quot. Variation %
1 semaine19,6820,3218,4219,13630 239-0,94-4,78%
1 mois22,9723,0018,4220,33819 877-4,23-18,42%
3 mois21,6728,2618,4223,48972 257-2,93-13,52%
6 mois21,0328,2616,5221,67904 787-2,29-10,89%
1 an43,3659,9916,51527,271 036 787-24,62-56,78%
3 ans73,7481,0016,51536,14750 678-55,00-74,59%
5 ans158,90193,5616,51551,80742 915-140,16-88,21%

Dernières Valeurs Consultées

Delayed Upgrade Clock